Diebold Nixdorf Statistics

Total Valuation

DBD has a market cap or net worth of $1.59 billion. The enterprise value is $3.98 billion.

Market Cap	1.59B
Enterprise Value	3.98B

Important Dates

The next confirmed earnings date is Wednesday, August 7, 2024, before market open.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

DBD has 37.57 million shares outstanding.

Shares Outstanding	37.57M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.53%
Owned by Institutions (%)	95.24%
Float	25.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	16.37
PS Ratio	0.46
Forward PS	0.41
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.04

Current Ratio	1.04
Quick Ratio	0.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-16.60%
Return on Capital (ROIC)	-11.14%
Revenue Per Employee	$166,143
Profits Per Employee	-$24,257
Employee Count	21,000
Asset Turnover	1.14
Inventory Turnover	4.30

Taxes

In the past 12 months, DBD has paid $119.40 million in taxes.

Income Tax	119.40M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	41.34
200-Day Moving Average	31.75
Relative Strength Index (RSI)	56.47
Average Volume (20 Days)	446,153

Short Selling Information

The latest short interest is 343,038, so 0.91% of the outstanding shares have been sold short.

Short Interest	343,038
Short Previous Month	343,511
Short % of Shares Out	0.91%
Short % of Float	1.37%
Short Ratio (days to cover)	2.15

Income Statement

In the last 12 months, DBD had revenue of $3.49 billion and -$509.40 million in losses. Loss per share was -$6.43.

Revenue	3.49B
Gross Profit	781.30M
Operating Income	-130.40M
Pretax Income	-390.00M
Net Income	-509.40M
EBITDA	-34.60M
EBIT	-157.00M
Loss Per Share	-$6.43

Full Income Statement

Balance Sheet

The company has $263.00 million in cash and $2.66 billion in debt, giving a net cash position of -$2.39 billion or -$63.68 per share.

Cash & Cash Equivalents	263.00M
Total Debt	2.66B
Net Cash	-2.39B
Net Cash Per Share	-$63.68
Equity (Book Value)	-1.49B
Book Value Per Share	-39.54
Working Capital	66.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$257.60 million and capital expenditures -$52.60 million, giving a free cash flow of -$310.20 million.

Operating Cash Flow	-257.60M
Capital Expenditures	-52.60M
Free Cash Flow	-310.20M
FCF Per Share	-$3.91

Full Cash Flow Statement

Margins

Gross margin is 22.39%, with operating and profit margins of -3.74% and -14.60%.

Gross Margin	22.39%
Operating Margin	-3.74%
Pretax Margin	-11.18%
Profit Margin	-14.60%
EBITDA Margin	-0.99%
EBIT Margin	-4.50%
FCF Margin	-8.89%

Dividends & Yields

DBD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.76%
Shareholder Yield	-0.76%
Earnings Yield	-32.04%
FCF Yield	-19.51%

Dividend Details

Analyst Forecast

The average price target for DBD is $39.50, which is -6.66% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$39.50
Price Target Difference	-6.66%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DBD has an Altman Z-Score of 0.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.51
Piotroski F-Score	2